This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vergès, B. Search for Related Content PubMed PubMed Citation Articles by Vergès, B. Related Collections Cardiovascular Endocrinology Diabetes and Insulin

Impact of Fasting Glycemia on Short-Term Prognosis after Acute Myocardial Infarction

Service d’Endocrinologie (B.V.) and Service de Cardiologie (J.-C.B., J.E.W., Y.C.), Centre Hospitalier Universitaire Bocage, 21034 Dijon, France; Laboratory of Experimental Cardiovascular Pathophysiology and Pharmacology (M.Z.), Institut Fédératif de Recherche 100, Faculties of Medicine and Pharmacy, University of Burgundy, 21000 Dijon, France; Service de Cardiologie (G.D.), Clinique de Fontaine, 21121 Fontaine les Dijon, France; Service de Cardiologie (Y.L.), Centre Hospitalier, 21140 Semur en Auxois, France; Service de Cardiologie (L.J.-M.), Centre Hospitalier, 21200 Beaune, France; and Service de Cardiologie (H.M.), Centre Hospitalier, 21400 Châtillon sur Seine, France

Address all correspondence and requests for reprints to: Bruno Vergès, Service d’Endocrinologie, Centre Hospitalier Universitaire Bocage, Bd Mal de Lattre de Tassigny, 21034 Dijon, France. E-mail: bruno.verges{at}chu-dijon.fr.

Objective: The prognosis of patients with acute myocardial infarction (MI), according to the new criteria for impaired fasting glucose (IFG) (FG 100–126 mg/dl), has not been evaluated.

Research Design and Methods: A total of 2353 patients with acute MI and surviving at d 5 after admission were analyzed for short-term morbidity and mortality. FG was obtained at d 4 and 5. Patients were classified as diabetes mellitus (known diabetes or FG 126 mg/dl), high IFG (110 FG < 126 mg/dl), low IFG (100 FG < 110 mg/dl), and normal fasting glucose (NFG) (FG < 100 mg/dl).

Results: Among the 2353 patients, 968 (41%) had diabetes mellitus, 262 (11%) had high IFG, 332 (14%) had low IFG, and 791 (34%) had NFG. Compared with NFG patients, 30-d cardiovascular mortality was increased in high but not low IFG subjects. In-hospital heart failure was increased in high IFG subjects (42 vs. 20% for NFG, P < 0.0001) but not low IFG subjects (21 vs. 20%). High IFG, but not low IFG, was an independent factor associated with 30-d cardiovascular mortality [odds ratio 2.33 (1.55–3.47)] and in-hospital heart failure [odds ratio 1.70 (1.36–2.07)]. The optimal threshold levels of FG on the receiver-operating characteristic curves were 114 and 112 mg/dl to predict mortality and in-hospital heart failure, respectively.

Conclusion: The present study, based on a nonselected cohort of MI patients, underscores the high prevalence of IFG (25%) and highlights the clinical relevance of 110 mg/dl, but not 100 mg/dl, as a cutoff value to define the risk for worse outcome.

This article has been cited by other articles:

				C. W.C. Kendall, A. Esfahani, A. J. Hoffman, A. Evans, L. M. Sanders, A. R. Josse, E. Vidgen, and S. M. Potter Effect of Novel Maize-based Dietary Fibers on Postprandial Glycemia and Insulinemia J. Am. Coll. Nutr., December 1, 2008; 27(6): 711 - 718. [Abstract] [Full Text] [PDF]

				M. Kosiborod Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 269 - 275. [Abstract] [PDF]